BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Tobii Technology AB Sees $21 Million for Eye Tracking Technology


3/20/2012 7:24:36 AM

STOCKHOLM--(BUSINESS WIRE)--Tobii Technology, the global leader in eye tracking and gaze interaction, announced today that it has closed a USD $21M funding round. New investor Intel Capital joins existing investors Amadeus Capital, Investor Growth Capital and Northzone Ventures. The funding will be used to continue R&D investments in core technology and to take eye tracking and gaze interaction to mainstream computers and other mass-market applications.

The new funding from Intel Capital will help Tobii to further accelerate the technological evolution and to take the leap into mass-market applications, such as mainstream computers, cars, games and other consumer and professional products. More specifically it will help Tobii to do necessary R&D investments, grow their R&D organization and build new strategic competences.

“Eye Tracking and gaze interaction has the potential to revolutionize computer interaction much the same way touch has changed hand-held devices,” said Henrik Eskilsson, CEO at Tobii Technology. “Tobii aims at taking eye tracking from niche markets to mass-market applications, in mainstream computing and automotive applications. This investment will help us to take this leap and to make the technological advancements necessary to maintain a leading position in eye tracking technology.”

“Intel Capital believes that eye-tracking could form an important part of Man machine interface. Tobii is a market segment leader in eye-tracking and a leading candidate to enable the latest generation of user-interface technology,” said Marcos Battisti, Managing Director for Intel Capital, Western Europe and Israel.

Effective from March 2012, Ian Cooper will be appointed to Tobii’s board of directors as the investor representative for Intel Capital. “I am looking forward to working with Tobii to build the leader in consumer-focused eye-tracking,” said Ian Cooper, Investment Director at Intel Capital.

”Eye-gaze tracking holds great promise as a novel method for user/machine interaction. Working closely with Tobii, we hope to bring the benefit of this new technology to personal computing,” said Joel Fisch, Director of Business Development at Intel’s Architecture Development Group. About Intel Capital Intel Capital, Intel's global investment and M&A organization, makes equity investments in innovative technology start-ups and companies worldwide. Intel Capital invests in a broad range of companies offering hardware, software, and services targeting enterprise, mobility, health, consumer Internet, digital media, semiconductor manufacturing and cleantech. Since 1991, Intel Capital has invested more than US$10.5 billion in over 1,218 companies in 51 countries. In that timeframe, 196 portfolio companies have gone public on various exchanges around the world and 291 were acquired or participated in a merger. In 2011, Intel Capital invested US$526 million in 158 investments with approximately 51 percent of funds invested outside the U.S. and Canada. For more information on Intel Capital and its differentiated advantages, visit www.intelcapital.com or follow @Intelcapital.

About Tobii Technology

Tobii Technology is the world leader in eye tracking and gaze technology, which makes it possible for computers to know exactly where users are looking. Implemented in comprehensive solutions for research and communication, Tobii’s leading eye tracking technology has already transformed research in many fields and has enabled communication for thousands of people with special needs. Tobii delivers market-leading eye tracking technology and OEM components to applications such as computers, gaming and vehicle safety systems. Founded in 2001, Tobii continues to achieve rapid annual growth and receive awards and recognition for its accomplishments. Based in Sweden, Tobii has a global presence, with offices in the U.S., China, Germany, Japan and Norway, as well as a worldwide network of resellers and partners. For more information, visit www.tobii.com.

This information was brought to you by Cision http://www.cisionwire.com

Contacts

Tobii Technology,

Sara Hyléen, Head of PR,

+46 709 16 16 41,

sara.hyleen@tobii.com

or

In the U.S.:

Focused Image for Tobii,

Kristina Messner,

703-678-6023,

kmessner@focusedimage.com


Read at BioSpace.com
Read at News Release
Read at News Release


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->